According to Stratistics MRC, the Global Patient Monitoring Devices Market is expected to reach $30.43 billion by 2022 growing at a CAGR of 8.24% during the forecast period. Increasing aged population and the growing demand for independent livelihood together with quality care and cost effective treatment are crucial growth propellers for the patient monitoring devices market. Economic downturn, uneven reimbursement regulations and saturation in developed countries are the factors impeding the market growth.
Browse Detail Report With TOC @
https://marketreportscenter.com/reports/283298/patient-monitoring-devices-global-market-outlook-2015-2022
Among the overall patient monitoring devices market the cardiac monitors segment held the largest share in 2015, while neuromonitoring devices segment is estimated to be the fastest growing segment by 2022. Owing to the growing incidences of obstructive sleep apnea and the increasing capnographs alternate applications the respiratory monitors segment is also expected to grow at a faster rate during the forecast period. North America is anticipated to record a strong market share by 2022. Fueled by the improved buying power and growing population Asia Pacific is going to be one of the significant markets in coming years.
Some of the key players in the market include Contec Medical Systems Co., Ltd, Covidien Public Limited, Roche Diagnostics Limited, General Electric Co., Mindray Medical International Limited, Nihon Kohden Corporation, Smiths Group plc, Abbott Laboratories, SunTech Medical, Inc., Siemens Healthcare, Drager Medical GmbH, Johnson & Johnson Inc, Masimo Corporation, Omron Healthcare and Philips Healthcare
What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the...